Exact Sciences M&A Summary
Exact Sciences has acquired 8 companies of its own, including 6 in the last 5 years. It has also divested 1 asset.
Exact Sciences’ largest acquisition to date was in 2019, when it acquired Genomic Health for $2.8B. It’s largest disclosed sale occurred in 2022, when it sold Exact Sciences - DX GPS Prostate Cancer Business to MDxHealth SA for $100M. Exact Sciences has acquired in 4 different US states, and 2 countries. The Company’s most targeted sectors include life science (75%) and healthcare services (25%).
M&A Summary
-
M&A Total Activity9
- M&A Buy Activity8
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 2